← FDA Drug Approvals (Drugs@FDA)

DIFFERIN

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2000-05-26

Drug application

FDA Application #
NDA020748
Application type
New Drug Application
Brand name
DIFFERIN
Generic name
ADAPALENE
Active ingredients
ADAPALENE
Dosage form
CREAM
Route
TOPICAL
Marketing status
Prescription
Sponsor
GALDERMA LABS LP
Manufacturer
GALDERMA LABORATORIES, L.P
First approval
2000-05-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown